news
08-29-2012, 12:28 AM
The British drug maker hopes Pascal Soriot can use his experience with biotechnology drugs to revive a company battered by clinical trial failures and patent expirations.http://rss.nytimes.com/c/34625/f/642565/s/22d54f52/mf.gif
More... (http://www.nytimes.com/2012/08/29/business/astrazenecas-next-ceo-is-pascal-soriot-of-roche.html?partner=rss&emc=rss)
More... (http://www.nytimes.com/2012/08/29/business/astrazenecas-next-ceo-is-pascal-soriot-of-roche.html?partner=rss&emc=rss)